Dr. Majd Michael, MD

Dr. Michael practices at Marshall Medical in Placerville, California, part of Marshall Medical Center.

Dr. Michael's NPI, 1306223177, was assigned on April 30, 2015. Dr. Michael graduated from Damascus University Faculty of Medicine in 2013. Dr. Michael holds California license A151364.

Dr. Michael's primary practice is Marshall Medical, at 1100 Marshall Way, Placerville, CA 95667 in El Dorado County. The practice phone is (530) 622-1441.

Dr. Michael's primary practice is Marshall Medical in Placerville, California, part of Marshall Medical Center. The medical group on file is Marshall Medical Center. Dmand AI also links Dr. Michael to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Michael practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Michael's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Michael is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Michael's licenses on file in 2 states: California and Texas.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, esophagus, stomach, or upper small intestine surgery, fatty liver and gastroenteritis among the conditions Dr. Michael treats.

CMS data shows 1,320 Medicare services from Dr. Michael across 17 procedure codes in 2024, for 571 Medicare patients. Medicare paid $112,778 for them.

CMS counts 571 Medicare patients who saw Dr. Michael in 2024. The largest group is 65 to 74, with 287 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Michael's median patient age at 67, with 51% women.

In 2024, Dr. Michael wrote 1,350 Medicare Part D claims for 544 patients. 80% of them were for generic drugs. CMS names the drug for 1,181 of them, across 22 drugs with 11 or more claims each, at $186,287 in total drug cost. In 2023, CMS named 735 claims across 17 drugs.

Dr. Michael accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Michael as offering telehealth. CMS counts 270 procedures of colonoscopy by Dr. Michael, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 13 papers to Dr. Michael, published from 2015 to 2021. 2018 was the busiest year, with 4. The most frequent topics are Catheter-Related Infections, Catheterization, Central Venous and Gram-Negative Bacterial Infections. Dr. Michael has published most often in Sci Rep. Dr. Michael's most frequent co-authors are Patrick Samir Chaftari, MD, Yi Jia, MD and Mohamed O. Othman, MD.

CMS Open Payments shows 53 general payments to Dr. Michael from 19 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 81% of the total. Boston Scientific Corporation paid the most, $462.

Dr. Michael graduated from Damascus University Faculty of Medicine in 2013.

Dr. Michael is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.